Safety and Bioavailability of IV and SC LBR-101

- Bioavailability and Pharmacokinetics
- Completed

Study Title: Safety and Bioavailability of IV and SC LBR-101

Teva Identifier: LBR-101-011

ClinicalTrials.gov Identifier: NCT01991509

Study Status: Completed

Trial Condition(s): Bioavailability and Pharmacokinetics

Interventions: Biological: LBR-101 IV | Biological: LBR-101 SC

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult

Age Range: 18 Years to 60 Years

Trial Duration: 10/01/2013 - 01/01/2015

Phase: Phase 1

Study Type

Interventional